×

Hep C revenue beats at Gilead

4:03 PM ET Tue, 28 July 2015

Giilead is reporting $3.15 adjusted on revenue of $8.2 billion, and worldwide hepatitis C revenues beat, reports CNBC's Meg Tirrell.